de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167a(4):756–67.

Article  PubMed  Google Scholar 

de Graaf G, Buckley F, Skotko BG. Live births, natural losses, and elective terminations with Down syndrome in Massachusetts. Genet Med. 2016;18(5):459–66.

Article  PubMed  Google Scholar 

Chicoine B, Rivelli A, Fitzpatrick V, Chicoine L, Jia G, Rzhetsky A. Prevalence of common disease conditions in a large cohort of individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2021;8(2):86–97.

Article  PubMed  PubMed Central  Google Scholar 

Startin CM, D’Souza H, Ball G, Hamburg S, Hithersay R, Hughes KMO, et al. Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020;12(1):4.

Article  PubMed  PubMed Central  Google Scholar 

Stagi S, Lapi E, Romano S, Bargiacchi S, Brambilla A, Giglio S, et al. Determinants of vitamin D levels in children and adolescents with Down syndrome. Int J Endocrinol. 2015;2015:896758.

Article  PubMed  PubMed Central  Google Scholar 

Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015;26(6):385–91.

Article  PubMed  Google Scholar 

Zubillaga P, Garrido A, Mugica I, Ansa J, Zabalza R, Emparanza JI. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down’s syndrome. Eur J Clin Nutr. 2006;60(5):605–9.

Article  CAS  PubMed  Google Scholar 

Nodehi M, Ajami A, Izad M, Asgarian Omran H, Chahardoli R, Amouzegar A, et al. Effects of vitamin D supplements on frequency of CD4(+) T-cell subsets in women with Hashimoto’s thyroiditis: a double-blind placebo-controlled study. Eur J Clin Nutr. 2019;73(9):1236–43.

Article  CAS  PubMed  Google Scholar 

Zhao R, Zhang W, Ma C, Zhao Y, Xiong R, Wang H, et al. Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front Immunol. 2021;12:574967.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation. 2015;22(6):400–4.

Article  CAS  PubMed  Google Scholar 

Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452.

Article  PubMed  PubMed Central  Google Scholar 

Altun H, Kurutaş EB, Şahin N, Güngör O, Fındıklı E. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders. Clin Psychopharmacol Neurosci. 2018;16(4):383–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molloy CA, Kalkwarf HJ, Manning-Courtney P, Mills JL, Hediger ML. Plasma 25(OH)D concentration in children with autism spectrum disorder. Dev Med Child Neurol. 2010;52(10):969–71.

Article  PubMed  PubMed Central  Google Scholar 

Esnafoglu E, Subaşı B. Association of low 25-OH-vitamin D levels and peripheral inflammatory markers in patients with autism spectrum disorder: vitamin D and inflammation in autism. Psychiatry Res. 2022;316:114735.

Article  CAS  PubMed  Google Scholar 

Zhang M, Wu Y, Lu Z, Song M, Huang X, Mi L, et al. Effects of vitamin D supplementation on children with autism spectrum disorder: a systematic review and meta-analysis. Clin Psychopharmacol Neurosci. 2023;21(2):240–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li B, Xu Y, Zhang X, Zhang L, Wu Y, Wang X, et al. The effect of vitamin D supplementation in treatment of children with autism spectrum disorder: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2022;25(4):835–45.

Article  CAS  PubMed  Google Scholar 

Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–52.

Article  PubMed  Google Scholar 

Petruzzelli MG, Marzulli L, Margari F, De Giacomo A, Gabellone A, Giannico OV, et al. Vitamin D deficiency in autism spectrum disorder: a cross-sectional study. Dis Markers. 2020;2020:9292560.

Article  PubMed  PubMed Central  Google Scholar 

Şengenç E, Kıykım E, Saltik S. Vitamin D levels in children and adolescents with autism. J Int Med Res. 2020;48(7):300060520934638.

Article  PubMed  Google Scholar 

Arastoo AA, Khojastehkia H, Rahimi Z, Khafaie MA, Hosseini SA, Mansouri MT, et al. Evaluation of serum 25-hydroxy vitamin D levels in children with autism spectrum disorder. Ital J Pediatr. 2018;44(1):150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corder JP, Al Ahbabi FJS, Al Dhaheri HS, Chedid F. Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates. Am J Med Genet A. 2017;173(9):2395–407.

Article  PubMed  Google Scholar 

Santoro JD, Partridge R, Tanna R, Pagarkar D, Khoshnood M, Rehmani M, et al. Evidence of neuroinflammation and immunotherapy responsiveness in individuals with Down syndrome regression disorder. J Neurodev Disord. 2022;14(1):35.

Article  PubMed  PubMed Central  Google Scholar 

Santoro SL, Baumer NT, Cornacchia M, Franklin C, Hart SJ, Haugen K, et al. Unexplained regression in Down syndrome: management of 51 patients in an international patient database. Am J Med Genet A. 2022;188(10):3049–62.

Santoro SL, Cannon S, Capone G, Franklin C, Hart SJ, Hobensack V, et al. Unexplained regression in Down syndrome: 35 cases from an international Down syndrome database. Genet Med. 2020;22(4):767–76.

Article  PubMed  Google Scholar 

Santoro JD, Lee S, Wang AC, Ho E, Nagesh D, Khoshnood M, et al. Increased autoimmunity in individuals with Down syndrome and moyamoya disease. Front Neurol. 2021;12:724969.

Article  PubMed  PubMed Central  Google Scholar 

Goksin S. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. North Clin Istanb. 2022;9(5):451–8.

PubMed  PubMed Central  Google Scholar 

Sassi F, Tamone C, D’Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018;10(11):1656. https://pubmed.ncbi.nlm.nih.gov/30400332/

Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061–94.

Article  PubMed  Google Scholar 

Prietl B, Treiber G, Mader JK, Hoeller E, Wolf M, Pilz S, et al. High-dose cholecalciferol supplementation significantly increases peripheral CD4+ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr. 2014;53(3):751–9.

Article  CAS  PubMed  Google Scholar 

Bock G, Prietl B, Mader JK, Höller E, Wolf M, Pilz S, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27(8):942–5.

Article  CAS  PubMed  Google Scholar 

Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - a randomized clinical trial. Clin Immunol. 2015;161(2):217–24.

Article  CAS  PubMed  Google Scholar 

Cao B, Wen T, Wei M, Xiong Y, Liu W, Zhu L, et al. Transcriptomic analysis reveal the responses of dendritic cells to VDBP. Genes Genomics. 2022;44(10):1271–82.

Article  CAS  PubMed  Google Scholar 

Navarro-Barriuso J, Mansilla MJ, Quirant-Sánchez B, Teniente-Serra A, Ramo-Tello C, Martínez-Cáceres EM. Vitamin D3-induced tolerogenic dendritic cells modulate the transcriptomic profile of T CD4(+) cells towards a functional hyporesponsiveness. Front Immunol. 2020;11:599623.

Article  CAS  PubMed  Google Scholar 

Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, et al. Analysis of the seasonal fluctuation of γδ T cells and its potential relation with vitamin D(3). Cells. 2022;11(9).

Sheikh V, Kasapoglu P, Zamani A, Basiri Z, Tahamoli-Roudsari A, Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum Immunol. 2018;79(6):439–45.

Article  CAS  PubMed  Google Scholar 

Siracusano M, Riccioni A, Abate R, Benvenuto A, Curatolo P, Mazzone L. Vitamin D deficiency and autism spectrum disorder. Curr Pharm Des. 2020;26(21):2460–74.

Article  PubMed  Google Scholar 

Galoppin M, Kari S, Soldati S, Pal A, Rival M, Engelhardt B, et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Commun. 2022;4(4):fcac171.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36.

Article